Model cell culture system for defining the molecular and biochemical events mediating terminal differentiation of human melanoma cells

Journal of Cellular Physiology

Volumn 218, Issue 2, 2009, Pages 304-314

  Staudt, Michelle R ^a   DePass, Anthony L ^b   Sarkar, Devanand ^a,c   Fisher, Paul B ^a,c,d  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b LONG ISLAND UNIVERSITY   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^d VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; PROTEIN KINASE C; DITERPENE; ENZYME ACTIVATOR; ISOENZYME; MEZEREIN; PROTEIN KINASE INHIBITOR;

ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CELL STRUCTURE; CHEMICAL ANALYSIS; CONTROLLED STUDY; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; MELANOMA CELL; MICROARRAY ANALYSIS; PRIORITY JOURNAL; CELL CYCLE; CELL PROLIFERATION; CLUSTER ANALYSIS; CULTURE TECHNIQUE; DNA MICROARRAY; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; MELANOMA; METABOLISM; METHODOLOGY; PATHOLOGY; PHENOTYPE; PROTEIN PROCESSING; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

CELL CULTURE TECHNIQUES; CELL CYCLE; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; CLUSTER ANALYSIS; DITERPENES; ENZYME ACTIVATORS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERFERON-BETA; ISOENZYMES; MELANOMA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; PROTEIN PROCESSING, POST-TRANSLATIONAL; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 58149237395     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21602     Document Type: Article

References (52)

1. Boukerche H, Su ZZ, Emdad L, Baril P, Balme B, Thomas L, Randolph A, Valerie K, Sarkar D, Fisher PB. 2005. mda-9/syntenin: A positive regulator of melanoma metastasis. Cancer Res 65:10901-10911.
2. Boukerche H, Su ZZ, Emdad L, Sarkar D, Fisher PB. 2007. mda-9/syntenin regulates the metastatic phenotype in human melanoma cells by activating nuclear factor-kappaB. Cancer Res 67:1812-1822.
3. Castagna M, Takai Y, Kaibuchi K, Sano K, Kikkawa U, Nishizuka Y. 1982. Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J Biol Chem 257:7847-7851.
4. Clark WH. 1991. Tumour progression and the nature of cancer. Br J Cancer 64:631-644.
5. Fisher PB. 2005. Is mda-7/IL-24 a "magic bullet" for cancer? Cancer Res 65:10128-10138.
6. Fisher PB, Grant S. 1985. Effects of interferon on differentiation of normal and tumor cells. Pharmacol Ther 27:143-166.
7. Fisher P, Rowley P. 1991. Regulation of growth, differentiation and antigen expression in human tumor cells by recombinant cytokines: Applications for the differentiation therapy of cancer. In: Rossi SaTF, editor. The status of differentiation therapy of cancer. New York: Raven Press. pp 201-213.
8. Fisher PB, Prignoli DR, Hermo H, Jr., Weinstein IB, Pestka S. 1985. Effects of combined treatment with interferon and mezerein on melanogenesis and growth in human melanoma cells. J Interferon Res 5:11-22.
9. Fisher PB, Miranda AF, Babiss LE. 1986. Measurement of the effect of interferons on cellular differentiation in murine and human melanoma cells. Methods Enzymol 119:611-618.
10. Graham GM, Guarini L, Moulton TA, Datta S, Ferrone S, Giacomini P, Kerbel RS, Fisher PB. 1991. Potentiation of growth suppression and modulation of the antigenic phenotype in human melanoma cells by the combination of recombinant human fibroblast and immune interferons. Cancer Immunol Immunother 32:382-390.
11. Hanahan D, Weinberg RA. 2000. The hallmarks of cancer. Cell 100:57-70.
12. Herlyn M. 1990. Human melanoma: Development and progression. Cancer Metastasis Rev 9:101-112.
13. Huang F, Adelman J, Jiang H, Goldstein NI, Fisher PB. 1999. Differentiation induction subtraction hybridization (DISH): A strategy for cloning genes displaying differential expression during growth arrest and terminal differentiation. Gene 236:125-131.
14. Inoue M, Kishimoto A, Takai Y, Nishizuka Y. 1977. Studies on a cyclic nucleotide-independent protein kinase and its proenzyme in mammalian tissues. II. Proenzyme and its activation by calcium-dependent protease from rat brain. J Biol Chem 252:7610-7616.
15. Iwamoto T, Hagiwara M, Hidaka H, Isomura T, Kioussis D, Nakashima I. 1992. Accelerated proliferation and interleukin-2 production of thymocytes by stimulation of soluble anti-CD3 monoclonal antibody in transgenic mice carrying a rabbit protein kinase C alpha. J Biol Chem 267:18644-18648.
16. Jiang H, Fisher PB. 1993. Gene expression changes induced in human melanoma cells undergoing reversible growth suppression and terminal cell differentiation. Mol Cell Diff 1:41-46.
17. Jiang H, Lin J, Su ZZ, Collart FR, Huberman E, Fisher PB. 1994. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene 9:3397-3406.
18. Jiang H, Lin J, Su ZZ, Herlyn M, Kerbel RS, Weissman BE, Welch DR, Fisher PB. 1995a. The melanoma differentiation-associated gene mda-6, which encodes the cyclin-dependent kinase inhibitor p21, is differentially expressed during growth, differentiation and progression in human melanoma cells. Oncogene 10:1855-1864.
19. Jiang H, Lin J, Young SM, Goldstein NI, Waxman S, Davila V, Chellappan SP, Fisher PB. 1995b. Cell cycle gene expression and E2F transcription factor complexes in human melanoma cells induced to terminally differentiate. Oncogene 11:1179-1189.
20. Jiang H, Lin JJ, Su ZZ, Goldstein NI, Fisher PB. 1995c. Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression. Oncogene 11:2477-2486.
21. Jiang H, Kang DC, Alexandre D, Fisher PB. 2000. RaSH, a rapid subtraction hybridization approach for identifying and cloning differentially expressed genes. Proc Natl Acad Sci USA 97:12684-12689.
22. Kang DC, Gopalkrishnan RV, Wu Q, Jankowsky E, Pyle AM, Fisher PB. 2002. mda-5: An interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties. Proc Natl Acad Sci USA 99:637-642.
23. Kang DC, Gopalkrishnan RV, Lin L, Randolph A, Valerie K, Pestka S, Fisher PB. 2004. Expression analysis and genomic characterization of human melanoma differentiation associated gene-5, mda-5: A novel type I interferon-responsive apoptosis-inducing gene. Oncogene 23:1789-1800.
24. Kerbel RS. 1990. Growth dominance of the metastatic cancer cell: Cellular and molecular aspects. Adv Cancer Res 55:87-132.
25. Kishimoto A, Takai Y, Mori T, Kikkawa U, Nishizuka Y. 1980. Activation of calcium and phospholipid-dependent protein kinase by diacylglycerol, its possible relation to phosphatidylinositol turnover. J Biol Chem 255:2273-2276.
26. Lahn MM, Sundell KL. 2004. The role of protein kinase C-alpha (PKC-alpha) in melanoma. Melanoma Res 14:85-89.
27. Lebedeva IV, Washington I, Sarkar D, Clark JA, Fine RL, Dent P, Curiel DT, Turro NJ, Fisher PB. 2007. Strategy for reversing resistance to a single anticancer agent in human prostate and pancreatic carcinomas. Proc Natl Acad Sci USA 104:3484-3489.
28. Leszczyniecka M, Roberts T, Dent P, Grant S, Fisher PB. 2001. Differentiation therapy of human cancer: Basic science and clinical applications. Pharmacol Ther 90:105-156.
29. Leszczyniecka M, Kang DC, Sarkar D, Su ZZ, Holmes M, Valerie K, Fisher PB. 2002. Identification and cloning of human polynucleotide phosphorylase, hPNPase old-35, in the context of terminal differentiation and cellular senescence. Proc Natl Acad Sci USA 99:16636-16641.
30. Li H, Weinstein IB. 2006. Protein kinase C beta enhances growth and expression of cyclin D1 in human breast cancer cells. Cancer Res 66:11399-11408.
31. Li H, Ahmed NU, Fenner MH, Ueda M, Isselbacher KJ, Shioda T. 1998. Regulation of expression of MSG1 melanocyte-specific nuclear protein in human melanocytes and melanoma cells. Exp Cell Res 242:478-486.
32. Lin JJ, Jiang H, Fisher PB. 1998. Melanoma differentiation associated gene-9, mda-9, is a human gamma interferon responsive gene. Gene 207:105-110.
33. Lin L, Su Z, Lebedeva IV, Gupta P, Boukerche H, Rai T, Barber GN, Dent P, Sarkar D, Fisher PB. 2006. Activation of Ras/Raf protects cells from melanoma differentiation-associated gene-5-induced apoptosis. Cell Death Differ 13:1982-1993.
34. Lu C, Kerbel RS. 1994. Cytokines, growth factors and the loss of negative growth controls in the progression of human cutaneous malignant melanoma. Curr Opin Oncol 6:212-220.
35. Lu Z, Liu D, Hornia A, Devonish W, Pagano M, Foster DA. 1998. Activation of protein kinase C triggers its ubiquitination and degradation. Mol Cell Biol 18:839-845.
36. Mandil R, Ashkenazi E, Blass M, Kronfeld I, Kazimirsky G, Rosenthal G, Umansky F, Lorenzo PS, Blumberg PM, Brodie C. 2001. Protein kinase C alpha and protein kinase C delta play opposite roles in the proliferation and apoptosis of glioma cells. Cancer Res 61:4612-4619.
37. Miller AJ, Mihm MC, Jr. 2006. Melanoma N Engl J Med 355:51-65.
38. Nair SS, Chaubal VA, Shioda T, Coser KR, Mojamdar M. 2001. Over-expression of MSG1 transcriptional co-activator increases melanin in B16 melanoma cells: A possible role for MSG1 in melanogenesis. Pigment Cell Res 14:206-209.
39. Ryu B, Kim DS, Deluca AM, Alani RM. 2007. Comprehensive expression profiling of tumor cell lines identifies molecular signatures of melanoma progression. PLoS ONE 2:e594.
40. Sarkar D, Park ES, Fisher PB. 2006. Defining the mechanism by which IFN-beta dowregulates c-myc expression in human melanoma cells: Pivotal role for human polynucleotide phosphorylase (hPNPaseold-35). Cell Death Differ 13:1541-1553.
41. Sarkar D, Boukerche H, Su ZZ, Fisher PB. 2008. mda-9/Syntenin: More than just a simple adapter protein when it comes to cancer metastasis. Cancer Res 68:3087-3093.
42. Shen L, Dean NM, Glazer RI. 1999. Induction of p53-dependent, insulin-like growth factor-binding protein-3-mediated apoptosis in glioblastoma multiforme cells by a protein kinase C alpha antisense oligonucleotide. Mol Pharmacol 55:396-402.
43. Shi G, Boyle SC, Sparrow DB, Dunwoodie SL, Shioda T, de Caestecker MP. 2006. The transcriptional activity of CITED1 is regulated by phosphorylation in a cell cycle-dependent manner. J Biol Chem 281:27426-27435.
44. Shioda T, Fenner MH, Isselbacher KJ. 1996. msg1, a novel melanocyte-specific gene, encodes a nuclear protein and is associated with pigmentation. Proc Natl Acad Sci USA 93:12298-12303.
45. Shioda T, Fenner MH, Isselbacher KJ. 1997. MSG1 and its related protein MRG1 share a transcription activating domain. Gene 204:235-241.
46. Sullivan RM, Stone M, Marshall JF, Uberall F, Rotenberg SA. 2000. Photo-induced inactivation of protein kinase calpha by dequalinium inhibits motility of murine melanoma cells. Mol Pharmacol 58:729-737.
47. Wang XY, Repasky E, Liu HT. 1999. Antisense inhibition of protein kinase C alpha reverses the transformed phenotype in human lung carcinoma cells. Exp Cell Res 250:253-263.
48. Waxman S. 1988. The importance of the induction of gene expression and differentiation by cytotoxic chemotherapy. Cancer Invest 6:747-753.
49. Ways DK, Kukoly CA, deVente J, Hooker JL, Bryant WO, Posekany KJ, Fletcher DJ, Cook PP, Parker PJ. 1995. MCF-7 breast cancer cells transfected with protein kinase C-alpha exhibit altered expression of other protein kinase C isoforms and display a more aggressive neoplastic phenotype. J Clin Invest 95:1906-1915.
50. Yahata T, de Caestecker MP, Lechleider RJ, Andriole S, Roberts AB, Isselbacher KJ, Shioda T. 2000. The MSG1 non-DNA-binding transactivator binds to the p300/CBP coactivators, enhancing their functional link to the Smad transcription factors. J Biol Chem 275:8825-8834.
51. Yan C, Sehgal PB, Tamm I. 1989. Signal transduction pathways in the induction of 2′,5′-oligoadenylate synthetase gene expression by interferon alpha/beta. Proc Natl Acad Sci USA 86:2243-2247.
52. Zhao W, Liu H, Xu S, Entschladen F, Niggemann B, Zanker KS, Han R. 2001. Migration and metalloproteinases determine the invasive potential of mouse melanoma cells, but not melanin and telomerase. Cancer Lett 162:S49-S55.